Solve compliance problems, lower costs & reduce risk
with trusted consulting and training to streamline
FDA compliance & strengthen your bottom line.
Find out how →
The first newsletter exclusively devoted to FDA, ICH and IMDRF compliance best practices, quality system advice, actionable regulatory intelligence, and cutting-edge product development strategies for biotechnology, pharmaceutical, and medical device executives.
"This should be mandatory reading for industry executives"
- Dan Michels, former FDA inspector
Drugmakers and medical device firms should expect at least 10% of their suppliers are “virtual companies,” often with only a single administrative office or just a post office box being their only tangible existence, said John Avellanet, founder and principal … Continue reading
Client Success Stories
“Cerulean's managing director immediately understood our needs and the agency's worries, and gave us a quick turn-around time. He was instrumental in creating a better solution and saving us.”
- Madeline Snow, Director, Lowell, Massachusetts